1. Home
  2. GNLX vs CPIX Comparison

GNLX vs CPIX Comparison

Compare GNLX & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genelux Corporation

GNLX

Genelux Corporation

HOLD

Current Price

$2.54

Market Cap

110.4M

Sector

Health Care

ML Signal

HOLD

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

HOLD

Current Price

$6.58

Market Cap

98.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNLX
CPIX
Founded
2001
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
110.4M
98.3M
IPO Year
2022
2007

Fundamental Metrics

Financial Performance
Metric
GNLX
CPIX
Price
$2.54
$6.58
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$17.25
N/A
AVG Volume (30 Days)
307.9K
69.5K
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
9.47
58.70
EPS
N/A
N/A
Revenue
$8,000.00
$42,010,949.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.75
52 Week Low
$2.29
$1.85
52 Week High
$8.54
$9.28

Technical Indicators

Market Signals
Indicator
GNLX
CPIX
Relative Strength Index (RSI) 42.93 38.10
Support Level $2.51 $5.55
Resistance Level $2.95 $8.27
Average True Range (ATR) 0.15 0.64
MACD -0.01 -0.21
Stochastic Oscillator 28.57 3.17

Price Performance

Historical Comparison
GNLX
CPIX

About GNLX Genelux Corporation

Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.

Share on Social Networks: